Smoking reduces breast tenderness during oral estrogen-progestogen therapy

Climacteric

Volumn 7, Issue 4, 2004, Pages 390-396

  Bjarnason, N H ^a   Jorgensen C ^a   Kremmer, H ^a   Alexandersen, P ^a   Christiansen, C ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Breast pain; Breast tenderness; Estrogen; Postmenopause; Progestogen; Smoking

Indexed keywords

CYPROTERONE ACETATE; DESOGESTREL; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTRADIOL VALERATE; GESTAGEN; GESTODENE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; PIPERAZINE ESTRONE SULFATE; PLACEBO;

ADULT; ARTICLE; BREAST TENDERNESS; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; INTERVIEW; MATERNAL AGE; POSTMENOPAUSE; PRIORITY JOURNAL;

BODY MASS INDEX; BREAST; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; PAIN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; SMOKING;

EID: 10944256354     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/13697130400012171     Document Type: Article

References (11)

1. Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J. Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000;95:726-31
2. The Writing Group for the PEPI trial. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. J Am Med Assoc 1996;276:1389-96
3. Jensen J, Christiansen C, Rødbro P. Cigarette smoking, serum estrogens and bone loss during hormone replacement therapy early after menopause. N Engl J Med 1985;313:973-5
4. Bjarnason NH, Christiansen C. The influence of thinness and smoking on bone loss and response to HRT in early postmenopausal women. J Clin Endocrinol Metab 2000;85:590-6
5. Andersen FS, Transbol I, Christiansen C. Is cigarette smoking a promotor of the menopause? Acta Med Scand 1982;212:137-9
6. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001;68:259-70
7. Cornuz J, Feskanich D, Willett WC, Colditz GA. Smoking, smoking cessation and risk of hip fracture in women. Am J Med 1999;106:311-4
8. Haarbo J, Hassager C, Jensen SB, Riis BJ, Christiansen C. Serum lipids, lipoproteins and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivates or 17-hydroxyprogesterone derivates. Am J Med 1991;90:584-9
9. Bjarnason NH, Byrjalsen I, Hassager C, Haarbo J, Christiansen C. Low dose estradiol in combination with gestodene to prevent early postmenopausal bone loss. Am J Obstet Gynecol 2000;183:550-60
10. Alexandersen P, Byrjalsen I, Christiansen C. Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects. Br J Obstet Gynaecol 2000;107:356-64
11. Bjarnason NH, Alexandersen P, Christiansen C. Number of years since menopause: spontaneous bone loss is dependent, but response to HRT is independent. Bone 2002;30:637-42